MedTrace Logo

Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia

NCT01150669 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2016-05-18

No results posted yet for this study

Summary

This research study is studying lestaurtinib with or with chemotherapy in samples from young patients with leukemia. Studying the effects of lestaurtinib with or without chemotherapy in cell samples from patients with cancer in the laboratory may help doctors learn more about the effects of this treatment on cancer cells. It may also help doctors identify biomarkers related to cancer.

Conditions

  • Childhood Acute Lymphoblastic Leukemia
  • Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

Interventions

OTHER

laboratory biomarker analysis

Samples are analyzed in laboratory studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Patrick Brown, MD · Children's Oncology Group

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01150669 on ClinicalTrials.gov